Highline Wealth Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10
Closed -$149 1028
2025
Q1
$149 Buy
+10
New +$154 ﹤0.01% 968
2023
Q4
Sell
-2
Closed -$27 429
2023
Q3
$35 Buy
+2
New +$42 ﹤0.01% 392
2023
Q1
Sell
-5
Closed -$134 350
2022
Q4
$140 Hold
5
﹤0.01% 326
2022
Q3
$117 Buy
+5
New +$151 ﹤0.01% 325

Other funds holding OGN

Highline Wealth Partners's OGN Position: Q2 2025 in Review

Highline Wealth Partners sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 10 shares — an estimated $149 sold.

Highline Wealth Partners first reported a position in OGN in Q3 2022 and held it in 4 quarters. The position peaked at $149 in Q1 2025. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Highline Wealth Partners reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Highline Wealth Partners sold 10 Organon & Co shares in Q2 2025, an estimated $149.
  • Highline Wealth Partners first reported a position in Organon & Co in Q3 2022 and held it in 4 quarters.
  • Highline Wealth Partners's Organon & Co position peaked at $149 in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Highline Wealth Partners's 13F filing for Q2 2025, filed 16 Jul 2025.